MTA2 and Alzheimer disease: Another notable differentially expressed TF, STAT1, demonstrated a different expression pattern across PiD (FDR-adjusted P = 4.61 × 10−14; table S4A) and AD (not statistically significant), implying its distinct involvement in the regulatory mechanisms underlying different neurodegenerative disorders or different stages of disorders.